Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Federal Trade Commission
Cantor Fitzgerald
Johnson and Johnson
Boehringer Ingelheim

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,251,912

« Back to Dashboard

Which drugs does patent 6,251,912 protect, and when does it expire?

Patent 6,251,912 protects GILOTRIF and is included in one NDA.

Summary for Patent: 6,251,912

Title: Substituted quinazoline derivatives
Abstract:This invention provides compounds of formula 1 having the structure ##STR1## wherein: X, R.sub.1, R.sub.2, R.sub.3, R.sub.4, Z, X, and n are as defined hereinbefore in the specification, which are useful as antineoplastic agents and in the treatment of certain kidney diseases, such as polycystic kidney disease.
Inventor(s): Wissner; Allan (Ardsley, NY), Tsou; Hwei-Ru (New City, NY), Johnson; Bernard D. (Stony Point, NY), Hamann; Philip R. (Garnerville, NY), Zhang; Nan (Suffern, NY)
Assignee: American Cyanamid Company (Madison, NJ)
Application Number:09/124,365
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer Ingelheim
afatinib dimaleate
TABLET;ORAL201292-001Jul 12, 2013RXYesNo6,251,912► SubscribeYY TREATMENT OF CANCER
Boehringer Ingelheim
afatinib dimaleate
TABLET;ORAL201292-002Jul 12, 2013RXYesNo6,251,912► SubscribeYY TREATMENT OF CANCER
Boehringer Ingelheim
afatinib dimaleate
TABLET;ORAL201292-003Jul 12, 2013RXYesYes6,251,912► SubscribeYY TREATMENT OF CANCER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Fish and Richardson
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus